112 related articles for article (PubMed ID: 11786529)
1. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
Baroudi G; Acharfi S; Larouche C; Chahine M
Circ Res; 2002 Jan; 90(1):E11-6. PubMed ID: 11786529
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G).
Baroudi G; Pouliot V; Denjoy I; Guicheney P; Shrier A; Chahine M
Circ Res; 2001 Jun; 88(12):E78-83. PubMed ID: 11420310
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
4. Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation.
Wan X; Wang Q; Kirsch GE
J Mol Cell Cardiol; 2000 Oct; 32(10):1873-84. PubMed ID: 11013131
[TBL] [Abstract][Full Text] [Related]
5. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
Makita N; Mochizuki N; Tsutsui H
Circ J; 2008 Jun; 72(6):1018-9. PubMed ID: 18503232
[TBL] [Abstract][Full Text] [Related]
6. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
[TBL] [Abstract][Full Text] [Related]
7. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
Itoh H; Shimizu M; Mabuchi H; Imoto K
J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.
Watanabe H; Nogami A; Ohkubo K; Kawata H; Hayashi Y; Ishikawa T; Makiyama T; Nagao S; Yagihara N; Takehara N; Kawamura Y; Sato A; Okamura K; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Shimizu W; Makita N
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457
[TBL] [Abstract][Full Text] [Related]
9. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
[TBL] [Abstract][Full Text] [Related]
10. MOG1: a new susceptibility gene for Brugada syndrome.
Kattygnarath D; Maugenre S; Neyroud N; Balse E; Ichai C; Denjoy I; Dilanian G; Martins RP; Fressart V; Berthet M; Schott JJ; Leenhardt A; Probst V; Le Marec H; Hainque B; Coulombe A; Hatem SN; Guicheney P
Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
Wang DW; Makita N; Kitabatake A; Balser JR; George AL
Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism associated with idiopathic ventricular fibrillation (IVF) mutations R1232W and T1620M in human cardiac sodium channels.
Vilin YY; Fujimoto E; Ruben PC
Pflugers Arch; 2001 May; 442(2):204-11. PubMed ID: 11417215
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in domain I of SCN5A cause Brugada syndrome.
Vatta M; Dumaine R; Antzelevitch C; Brugada R; Li H; Bowles NE; Nademanee K; Brugada J; Brugada P; Towbin JA
Mol Genet Metab; 2002 Apr; 75(4):317-24. PubMed ID: 12051963
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.
Itoh H; Shimizu M; Takata S; Mabuchi H; Imoto K
J Cardiovasc Electrophysiol; 2005 May; 16(5):486-93. PubMed ID: 15877619
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.
Makita N; Shirai N; Wang DW; Sasaki K; George AL; Kanno M; Kitabatake A
Circulation; 2000 Jan 4-11; 101(1):54-60. PubMed ID: 10618304
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.
Hu D; Barajas-Martinez H; Burashnikov E; Springer M; Wu Y; Varro A; Pfeiffer R; Koopmann TT; Cordeiro JM; Guerchicoff A; Pollevick GD; Antzelevitch C
Circ Cardiovasc Genet; 2009 Jun; 2(3):270-8. PubMed ID: 20031595
[TBL] [Abstract][Full Text] [Related]
18. SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells.
Baroudi G; Carbonneau E; Pouliot V; Chahine M
FEBS Lett; 2000 Feb; 467(1):12-6. PubMed ID: 10664447
[TBL] [Abstract][Full Text] [Related]
19. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
20. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.
Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M
Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
